[The Petri Dish] RNAi and related patentability issues
RNA interference (RNAi) is an evolutionally highly conserved process of post transcriptional gene silencing (PTGs) by which double stranded RNA (ds RNA) causes sequence specific degradation of mRNA sequences. RNAi is a biological process in which RNA molecules inhibit gene expression, typically by causing the destruction of specific mRNA molecules. RNAi technology is widely applied […]
[Business Today] Innovation: Improving Lives
[The Petri Dish] Innovation: Improves Live
Innovation: Improving Lives
By P. Kandiah The inconvenience of fitting and using a dust bag in a vacuum cleaner inspired Sir James Dyson (as he is referred to now) to develop a bag-less vacuum cleaner which innovation has brought much comfort to those tasked with vacuuming floors. Dyson’s bag-less vacuum cleaner has taken the world by surprise. Pharmaceutical firms […]
[Pharma Times] Patentability and Litigation in Malaysia with a focus on Pharma Industry
[The Petri Dish] A billion-dollar Question
Genetic diseases and disorders which are caused by faulty genes in cells are debilitating and worsen the quality of life of a patient. But what if you could return the faulty genes to normalcy as easily as fixing your profile picture with Photoshop? Or even create a designer baby with desired features? A gene-editing tool […]
Generics vs. Patented Drugs
By Samini Thiruchelvam & P. Kandiah India’s incredible advancement in various fields of technology (including launching its own first ever Mars mission!) has attracted other nations to establish a trading relationship with India. This is further exemplified by President Obama’s recent visit to India in pursuant of a Free Trade Agreement (FTA) with the fast-developing […]
[The Petri Dish] Generics vs Patented Drugs
The Bolar Provision: A Defense to Patent Infringement
By P. Kandiah & Kimberly Liam What happens when a patent for a particular drug expires or is about to expire? Patented drugs lose their patent exclusivity as they go off patent and pharmaceutical companies that own these patents start to worry as the generic pharmaceutical companies begin to sell their drugs in the market. […]